文献速递头颈部肿瘤放疗放疗物理与技术

稳健治疗计划对单侧头颈部靶区质子束治疗单野与多野优化计划的影响

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes.
PubMed 文献 · Radiat Oncol · 2017-11-28

本研究对8例单侧头颈部靶区患者计算了4种铅笔束扫描质子治疗计划:单野优化和多野优化,分别采用PTV概念或基于CTV的稳健优化。结果显示所有名义计划均满足靶区覆盖临床要求,但单野优化方法同侧腮腺剂量显著更高,多野优化PTV计划对距离和摆位误差的稳健性最低。稳健多野优化被推荐用于确保计划稳健性和降低同侧腮腺剂量,治疗过程中解剖变化可能降低靶区覆盖并增加危及器官剂量,部分患者可能需要计划自适应。

要点

  • 推荐使用稳健多野优化以确保计划稳健性并降低同侧腮腺剂量。
  • 多野优化PTV计划对距离和摆位误差的稳健性最低。
  • 治疗中解剖变化对剂量的影响因患者而异,部分患者需计划自适应。

核心结论

  • 推荐使用稳健多野优化以确保计划稳健性并降低同侧腮腺剂量。
  • 治疗过程中解剖变化可能降低靶区覆盖并增加危及器官剂量,与所选计划方法无关。
  • 部分患者可能需要计划自适应。

研究设计与样本

  • 为8例单侧头颈部靶区患者计算了4种铅笔束扫描质子治疗计划:单野优化和多野优化,分别采用PTV概念或基于CTV的稳健优化。
  • 在治疗过程中获取的CT扫描上重新计算剂量,比较名义计划、考虑解剖变化的累积剂量以及每次分次附加摆位和距离误差的剂量。
  • 必要时进行计划自适应,并将剂量与未自适应计划进行比较。

主要发现

  • 所有名义计划均满足靶区覆盖的临床规格。
  • 两种单野优化方法同侧腮腺剂量显著更高。
  • 多野优化PTV计划对距离和摆位误差的稳健性最低。
  • 治疗过程中解剖变化对剂量的影响因患者而异,大多与所选计划方法无关。
  • 4例患者共9个计划需要自适应,与未自适应的累积剂量相比,自适应显著改善了靶区覆盖并轻微降低了危及器官剂量。

临床怎么用

  • 对于单侧头颈部靶区质子治疗,优先采用稳健多野优化以保障计划稳健性并降低同侧腮腺剂量。
  • 治疗过程中需关注解剖变化对靶区覆盖和危及器官剂量的影响,必要时进行计划自适应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Proton beam therapy is promising for the treatment of head and neck cancer (HNC), but it is sensitive to uncertainties in patient positioning and particle range. Studies have shown that the planning target volume (PTV) concept may not be sufficient to ensure robustness of the target coverage. A few planning studies have considered irradiation of unilateral HNC targets with protons, but they have only taken into account the dose on the nominal plan, without considering anatomy changes occurring during the treatment course. METHODS: Four pencil beam scanning (PBS) proton therapy plans were calculated for 8 HNC patients with unilateral target volumes: single-field (SFO) and multi-field optimized (MFO) plans, either using the PTV concept or clinical target volume (CTV)-based robust optimization. The dose was recalculated on computed tomography (CT) scans acquired during the treatment course. Doses to target volumes and organs at risk (OARs) were compared for the nominal plans, cumulative doses considering anatomical changes, and additional setup and range errors in each fraction. If required, the treatment plan was adapted, and the dose was compared with the non-adapted plan. RESULTS: All nominal plans fulfilled the clinical specifications for target coverage, but significantly higher doses on the ipsilateral parotid gland were found for both SFO approaches. MFO PTV-based plans had the lowest robustness against range and setup errors. During the treatment course, the influence of the anatomical variation on the dose has shown to be patient specific, mostly independent of the chosen planning approach. Nine plans in four patients required adaptation, which led to a significant improvement of the target coverage and a slight reduction in the OAR dose in comparison to the cumulative dose without adaptation. CONCLUSIONS: The use of robust MFO optimization is recommended for ensuring plan robustness and reduced doses in the ipsilateral parotid gland. Anatomical changes occurring during the treatment course might degrade the target coverage and increase the dose in the OARs, independent of the chosen planning approach. For some patients, a plan adaptation may be required.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Cubillos-Mesías M, Baumann M, Troost EGC, et al. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes. Radiat Oncol. 2017. PMID: 29183377. doi:10.1186/s13014-017-0931-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。